Tu canal independiente de oncología en español
Top resúmenes y presentaciones
ESMO 2024
GINECOLÓGICO
OVARIO
A Phase 1/2 study of Rinatabart Sesutecan (Rina-S) in
Patients with Advanced Ovarian or Endometrial Cancer
719MO
ATHENA-COMBO, a phase 3, randomized trial comparing
rucaparib (RUCA) + nivolumab (NIVO) combination therapy
vs RUCA monotherapy as maintenance treatment in
patients (pts) with newly diagnosed ovarian cancer (OC)
LBA30
ICON9: International phase III randomized study to evaluate
the efficacy of maintenance therapy with olaparib and
cediranib or olaparib alone in patients with relapsed
platinum-sensitive ovarian cancer following a response to
platinum-based chemotherapy
LBA33
Outcomes of BRCA and in-house homologous
recombination deficiency (HRD) testing in women with
ovarian and breast cancer: A multicentre registry study
LBA64
Final overall survival (OS) in patients (pts) with newly
diagnosed advanced ovarian cancer (aOC) treated with
niraparib (nir) first-line (1L) maintenance: results from
PRIMA/ENGOT-OV26/GOG-3012
LBA29
Regístrate aquí para recibir más contenidos
Registrarse